FDA 483 - Emcure Pharmaceuticals Limited - February 20, 2019
Discuss this record with AI
Document or profile
One record shows the event. A profile shows the pattern.
Buy this document for the source file and details behind this single event.
Choose full profile access to connect related records, sites, people, citations, and enforcement history in one view.
Emcure Pharmaceuticals Limited in Hinjwadi, India, was cited with six observations during an FDA inspection for manufacturing sterile and non-sterile drug products. The inspection revealed significant deficiencies in quality control, aseptic processing, environmental monitoring, laboratory procedures, and record-keeping, indicating a lack of thoroughness in investigations and adherence to established protocols. These issues collectively suggest a compromised state of control over sterile manufacturing operations and data integrity.
ID · 827e00cd-a343-4d28-a7f1-e66430275403